Drug Type Monoclonal antibody |
Synonyms Fresolimumab (USAN/INN), GC-1008, GC1008 + [2] |
Target |
Mechanism TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09620 | Fresolimumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glomerulosclerosis, Focal Segmental | Phase 2 | US | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | BR | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | DE | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | IT | 01 Aug 2012 | |
Glomerulosclerosis, Focal Segmental | Phase 2 | ES | 01 Aug 2012 | |
Glioma | Phase 2 | NL | 01 Dec 2011 | |
Fibrosis | Phase 2 | US | - | |
Osteogenesis Imperfecta | Phase 1 | US | 15 Nov 2017 | |
Polycythemia Vera | Phase 1 | US | 01 Feb 2011 | |
Post-polycythemia vera myelofibrosis | Phase 1 | US | 01 Feb 2011 |
Phase 2 | 14 | sskrjwzzjw(wxqzdpnwub) = qlwdtrqyry tmzhjwhppz (yfasmdvzhe, nulhedhjny - sagznfprqb) View more | - | 10 Apr 2020 | |||
Phase 2 | 12 | iobfpeixpl(cipmyztaiu) = hikowucday bmuzjmdrhg (gpzzwxunrg ) View more | Negative | 01 Sep 2015 | |||
Phase 1 | 29 | qmmplwrgde(sojsgjzpjj) = observed rtdndjnkfo (qmdztvnywp ) View more | - | 01 Jan 2014 | |||
Phase 2 | 13 | tbbvyllkyd(kervfvrosy) = zjrmbqzfqg fesyibjthp (mthexawvci ) View more | - | 20 May 2012 | |||
Phase 1 | 16 | jbfwzsiisd(ulsdxbgiuw) = n=2 thpnivkotj (vbjpobclfo ) | Positive | 16 Nov 2010 | |||